Immune cells can be altered to help fight inflammatory diseases, research finds

October 11, 2012

(Medical Xpress)—A fundamental mechanism controlling cells of the human immune system could be key to helping fight inflammatory diseases such as rheumatoid arthritis and psoriasis, new research at the University of Dundee has found.

The research by Dr Kris Clark, in the Medical Research Council Unit (MRC-PPU) at Dundee, concentrated on the activity of macrophages, which are cells of the immune system that defend the body against infection by bacteria and viruses.

Dr Clark found that an enzyme called SIK is active in suppressing the production of anti-inflammatory molecules. By 'switching off' the function of SIK within the cell, he was able to greatly enhance the production of beneficial anti-inflammatory molecules.

The research suggests that drugs that switch off SIK may improve current therapies for treating inflammatory diseases, such as and psoriasis.

"These are very exciting times for our research," said Dr Clark. "This discovery represents the first link between SIK and inflammation. My immediate future goal is to characterize in more detail the roles that SIK plays in the immune system and how they are affected by compounds that switch off this enzyme."

The research has been published in the .

Macrophages are cells of the immune system that defend the body against infection by bacteria and viruses. However, once these invading pathogens have been destroyed, the inflammatory responses triggered by macrophages have to be stopped, to avoid the development of .

Macrophages also play key roles in terminating the by switching on the production of so-called anti-inflammatory molecules.

Kris discovered that the production of anti-inflammatory molecules by is prevented by an enzyme called SIK and that, by turning off the function of SIK within the cell, he was able to greatly enhance the production of beneficial anti-inflammatory molecules while stopping the production of the molecules that cause inflammation.

Working with the Drug Discovery Unit at Dundee, Dr Clark has now started to develop molecules which could provide the basis for drugs to turn off SIK.

"My studies have greatly benefitted from working in the multi-disciplinary and collegial environment that has been built up in the MRC Unit, the Scottish Institute for Cell Signalling and the College of Life Sciences at Dundee," said Dr Clark. "My interactions with the scientists who work here and the advice they have given me has not only been invaluable for this project, but also most enjoyable."

Explore further: Study identifies novel role for a protein that could lead to new treatments for rheumatoid arthritis

Related Stories

Recommended for you

Anti-inflammatory mechanism of dieting and fasting revealed

February 16, 2015

Researchers at Yale School of Medicine have found that a compound produced by the body when dieting or fasting can block a part of the immune system involved in several inflammatory disorders such as type 2 diabetes, atherosclerosis, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.